PressReleases Investors Home Press Releases Events & Presentations Financials & Filings Stock Information Governance Year All2024202320222021202020192018 Sep 10, 2024 Mural Oncology to Host First Virtual Investor Day on September 26, 2024 Sep 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 27, 2024 Mural Oncology to Present at Two Upcoming Investor Conferences Aug 13, 2024 Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress Aug 02, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 31, 2024 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors Jul 02, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 05, 2024 Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference Jun 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 23, 2024 Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting Print page >> Contact us >> RSS >> Email alerts >>
Year All2024202320222021202020192018 Sep 10, 2024 Mural Oncology to Host First Virtual Investor Day on September 26, 2024 Sep 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 27, 2024 Mural Oncology to Present at Two Upcoming Investor Conferences Aug 13, 2024 Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress Aug 02, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 31, 2024 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors Jul 02, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 05, 2024 Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference Jun 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 23, 2024 Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
Aug 13, 2024 Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
Jul 31, 2024 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
Jun 05, 2024 Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
May 23, 2024 Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
